Characterization of habits and crystalline modification of solids and their pharmaceutical applications.

[1]  E. Nelson,et al.  Physicochemical properties of drugs that control absorption rate after subcutaneous implantation. , 1962, The Journal of pharmacology and experimental therapeutics.

[2]  J. Freyhof,et al.  Physiochemical factors influencing the absorption of the anhydrous and trihydrate forms of ampicillin. , 1968, Current therapeutic research, clinical and experimental.

[3]  Practical optical crystallography , 1965 .

[4]  M. Hagan.  Clathrate inclusion compounds , 1962 .

[5]  Alan Holden,et al.  Crystals and crystal growing , 1960 .

[6]  B. Pedersen.  NMR in Hydrate Crystals: Correction for Vibrational Motion , 1964 .

[7]  R. Tawashi,et al.  Inhibited dissolution of drug crystals by certified water-soluble dyes. II. , 1971, Journal of pharmaceutical sciences.

[8]  H. Mcadie.  THERMAL DECOMPOSITION OF MOLECULAR COMPLEXES: I. UREA-n-PARAFFIN INCLUSION COMPOUNDS , 1962 .

[9]  R. Kahn,et al.  Crystal structure of cyclohexane I and II , 1973 .

[10]  J. Guillory,et al.  Polymorphism in sulfanilamide-d4. , 1970, Journal of pharmaceutical sciences.

[11]  J. H. Rayner,et al.  67. Structure of molecular compounds. Part X. Crystal structure of the compound of benzene with an ammonia–nickel cyanide complex , 1952 .

[12]  L. S. Shenouda.  Various species of sulfathiazole form I. , 1970, Journal of pharmaceutical sciences.

[13]  H. Kuwano,et al.  Polymorphism of Long-chain Esters of Chloramphenicol. I: On Transition@@@転移について , 1961 .

[14]  A. Aguiar.  Dilatometric behavior of polymorphic forms of chloramphenicol palmitate. , 1969, Journal of pharmaceutical sciences.

[15]  M. Kuhnert-Brandstätter,et al.  Polymorphie und Mischkristallbildung bei Sulfonamiden und verwandten Verbindungen , 1969 .

[16]  P. E. Olesen,et al.  Crystallization of Gramicidin , 1959, Nature.

[17]  H. M. Powell.  15. The structure of molecular compounds. Part IV. Clathrate compounds , 1948 .

[18]  A. A. Silvidi,et al.  Motion of the H2O Molecule in Barium Chlorate Monohydrate , 1963 .

[19]  R. J. Cross,et al.  Clathration as a Practical Method for Handling Dimethylmercury , 1973, Nature.

[20]  D. Saville,et al.  Aspirin dissolution: polymorphism, crystal habit or crystal defects , 1971, The Journal of pharmacy and pharmacology.

[21]  L. J. Ravin,et al.  Physical-chemical evaluation of 3-(3-hydroxy-3-methylbutylamino)-5-methyl-as, triazino [5,6-b] indole (SK&F 30097). , 1970, Journal of pharmaceutical sciences.

[22]  H. M. Powell.  64. The structure of molecular compounds. Part VIII. The compound of krypton and quinol , 1950 .

[23]  J. Biles,et al.  Effect of crystallizing solvent on absorption rates of steroid implants , 1964 .

[24]  J. V. D. Waals.  The statistical mechanics of clathrate compounds , 1956 .

[25]  J. Biles,et al.  Isolation and characterization of some solid phases of fluprednisolone. , 1971, Journal of pharmaceutical sciences.

[26]  A. Parker,et al.  Polymorphism of cephaloridine , 1968, The Journal of pharmacy and pharmacology.

[27]  J. Whetstone.  945. Crystal symmetry, and the adsorption of dyes by growing crystals. Part I. Ammonium nitrate IV , 1956 .

[28]  R. Rudman,et al.  Polymorphism of the crystalline methylchloromethane compounds. III. Differential scanning calorimetric study , 1970 .

[29]  P. Michel,et al.  Polymorphisme du p-chlorophénol. I. Structure cristalline et morphologie de la forme stable , 1973 .

[30]  J. E. Carless,et al.  Application of differential scanning calorimetry to the study of sulphathiazole crystal forms , 1969, The Journal of pharmacy and pharmacology.

[31]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.

[32]  M. Kuhnert-Brandstätter.  Thermomicroscopy in the analysis of pharmaceuticals , 1971 .

[33]  J. Biles,et al.  Comparison of dissolution rates of different crystalline phases of fluprednisolone by in vitro and in vivo methods. , 1971, Journal of pharmaceutical sciences.

[34]  C. Courseille,et al.  Structure cristallines et moléculaires de trois formes polymorphes de l'oestrone , 1973 .

[35]  R. Hatcher.  THE UNITED STATES PHARMACOPEIA. , 1908 .

[36]  S. Khalil,et al.  Sulphamethoxydiazine crystal forms , 1971, The Journal of pharmacy and pharmacology.

[37]  L. Pauling.  THE HYDRATE MICROCRYSTAL THEORY OF GENERAL ANESTHESIA* , 1964, Anesthesia and analgesia.

[38]  R. Roy,et al.  Sulfur Melting and Polymorphism under Pressure: Outlines of Fields for 12 Crystalline Phases , 1969, Science.

[39]  T. Nagai,et al.  Dissolution Phenomena of Organic Medicinals involving Simultaneous Phase Changes , 1969 .

[40]  J. E. Carless,et al.  The polymorphism of aspirin , 1970, The Journal of pharmacy and pharmacology.

[41]  R. E. Marsh,et al.  The Structure of Chlorine Hydrate. , 1952, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Bugg,et al.  Crystal structure of calcium chloride tetrahydrate , 1973 .

[43]  J. W. Shell.  Crystallographic Data. 99. Hydrocortisone Acetate , 1955 .

[44]  R. Pfeiffer.  Aspirin polymorphism questioned , 1971, The Journal of pharmacy and pharmacology.

[45]  Y. Tsuda,et al.  Dissolution Behavior of Solid Drugs. III. Determination of the Transition Temperature between the Hydrate and Anhydrous Forms of Phenobarbital by Measuring Their Dissolution Rates , 1973 .

[46]  R. Bhattacharjee,et al.  Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension. , 1971, Journal of Pharmacy and Science.

[47]  S. Khalil,et al.  Effect of additives on the kinetics of interconversion of sulphamethoxydiazine crystal forms , 1973, The Journal of pharmacy and pharmacology.

[48]  J. Guillory,et al.  Polymorphism in sulfonamides. , 1972, Journal of pharmaceutical sciences.

[49]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .

[50]  K. Sekiguchi,et al.  Dissolution Behavior of Solid Drugs. II. Determination of the Transition Temperature of Sulfathiazole Polymorphs by Measuring the Initial Dissolution Rates , 1973 .

[51]  63. The structure of molecular compounds. Part VII. Compounds formed by the inert gases , 1950 .

[52]  A J Aguiar,et al.  Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid. , 1969, Journal of pharmaceutical sciences.

[53]  E. Shefter,et al.  DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS. , 1963, Journal of pharmaceutical sciences.

[54]  R. Tawashi,et al.  Aspirin: Dissolution Rates of Two Polymorphic Forms , 1968, Science.

[55]  A. C. Marshall,et al.  Crystalline Modifications of Ampicillin , 1965, Nature.

[56]  J. Randall,et al.  Atomic Physics and Related Subjects.: Communications to Nature.: The Diffraction of X-Rays by Vitreous Solids and its Bearing on their Constitution. , 1930, Nature.

[57]  S. Lin.  Preformulation investigation. II. Dissolution kinetics and thermodynamic parameters of polymorphs of an experimental antihypertensive. , 1972, Journal of pharmaceutical sciences.

[58]  J. Biles.  SOME CRYSTALLINE MODIFICATIONS OF THE TERT-BUTYLACETATES OF PREDNISOLONE AND HYDROCORTISONE. , 1963, Journal of pharmaceutical sciences.

[59]  W. Mccrone,et al.  Solid-state chemistry of cromolyn sodium (disodium cromoglycate). , 1971, Journal of pharmaceutical sciences.

[60]  R. Hoff,et al.  The Sulfur Hexafluoride Clathrate of Dianin's Compound (4-p-Hydroxyphenyl-2,2,4-trimethylchroman): Preparation, Characterization and Thermal Decomposition , 1960 .

[61]  F. E. Roberts,et al.  Effect of Crystalline Form on the Air-Oxidation of Steroidal 11β-ols to 11-ones , 1969 .

[62]  R. Mesley.  The polymorphism of sulphathiazole , 1971, The Journal of pharmacy and pharmacology.

[63]  M. Miyamoto,et al.  Differential Scanning Calorimetry of Chloramphenicol Palmitate and the Phase-Transitional Behavior of Chloramphenicol Palmitate observed during the Preparation of Its Oral Suspension , 1973 .

[64]  H. M. Powell.  New Procedures for Resolution of Racemic Substances , 1952, Nature.

[65]  The National Formulary , 1945 .

[66]  R. Tawashi.  Gastrointestinal absorption of two polymorphic forms of aspirin , 1969, The Journal of pharmacy and pharmacology.

[67]  M. Kuhnert-Brandstätter,et al.  Zur Unterscheidung von lösungsmittelhaltigen pseudopolymorphen Kristallformen und polymorphen Modifikationen bei Steroidhormonen. I , 1968 .

[68]  P. Gasser,et al.  Solvates and polymorphic modifications of steroid hormones. I , 1971 .

[69]  S. Khalil,et al.  Kinetics of interconversion of sulphamethoxydiazine crystal forms , 1972, The Journal of pharmacy and pharmacology.

[70]  G. Pake.  Nuclear Resonance Absorption in Hydrated Crystals: Fine Structure of the Proton Line , 1948 .

[71]  J. Whetstone.  The crystal habit modification of inorganic salts with dyes. Part 1.—General considerations , 1955 .

[72]  L. Pauling.  A molecular theory of general anesthesia. , 1961, Science.

[73]  T. Nagai,et al.  Dissolution Kinetics of Barbital Polymorphs , 1969 .

[74]  S. Khalil,et al.  GI absorption of two crystal forms of sulfameter in man. , 1972, Journal of pharmaceutical sciences.